Rising ADHD Diagnoses and the Push for Safer Care
A growing number of children are being diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), leading to increased demand for treatment. However, concerns are mounting over the safety of rapidly expanding private ADHD clinics, particularly those relying heavily on remote consultations. Recent warnings from doctors in Greater Manchester have triggered a significant overhaul of prescribing rules, prioritizing in-person assessments to protect vulnerable children.
The Risks of Remote-Only ADHD Assessments
The surge in video-only consultations has created what clinicians describe as “widespread and unsafe practice.” Doctors are reporting cases of children being prescribed powerful stimulant medications, such as methylphenidate (Ritalin), without adequate physical examinations. Rashad Nawaz, a consultant paediatrician in Manchester and Liverpool, has highlighted the dangers, revealing he has treated young patients with potential underlying heart conditions who were prescribed medication by online providers without any in-person checks.
One case involved a child diagnosed with a ventricular septal defect (VSD), or hole in the heart, after receiving medication from a national online provider. This condition was not identified during the remote assessment. Nawaz stated that he identified three children in the past year with previously unknown heart murmurs, none of whom had symptoms, but one of whom had a VSD.
Greater Manchester Leads the Way in Safety Reforms
In response to these concerns, NHS Greater Manchester has implemented a new “safety first” pathway. This requires face-to-face assessments and physical health checks before any ADHD medication is prescribed. While the region continues to honor the “Right to Choose” scheme – allowing families to access private care funded by the NHS – providers must now demonstrate a robust in-person clinical assessment process.
The Strain on the NHS and the Rise of Private Providers
The NHS is facing record demand for ADHD services, contributing to long waiting lists. This has fueled the growth of private providers, many of whom now hold NHS contracts. However, senior clinicians, like Prof Marios Adamou, argue that some private companies lack the necessary infrastructure to ensure patient safety. Adamou notes that GPs are often asked to perform checks for private services, placing them in a difficult position regarding clinical responsibility.
Concerns Over Workforce “Deskilling”
Nawaz similarly expressed concern about a potential “deskilling” of the workforce, with health professionals trained primarily in adult care treating children without sufficient paediatric experience. He cited instances of medication being prescribed via video link despite a family history of congenital heart disease, a critical detail overlooked by the private provider.
What the Research Says About ADHD Medication
Despite the safety concerns surrounding assessments, research suggests the benefits of ADHD medication generally outweigh the risks. A study from the University of Southampton found that the benefits of taking drugs for ADHD outweigh the impact of increases in blood pressure and heart rate. However, National Institute for Health and Care Excellence (NICE) guidelines clearly state that a full physical assessment, including a cardiovascular history and heart examination, is mandatory before treatment begins.
Future Trends and Potential Challenges
The situation in Greater Manchester signals a potential nationwide trend towards stricter regulation of private ADHD services. Expect to see increased scrutiny of remote assessment practices and a greater emphasis on in-person evaluations. The challenge will be balancing the need for timely access to care with the paramount importance of patient safety. Increased demand, coupled with limited NHS resources, will likely continue to drive families towards private options, making robust oversight even more critical.
Frequently Asked Questions
- What is the “Right to Choose” scheme? It allows NHS patients to choose to receive their care from a private provider, funded by the NHS.
- Why are in-person assessments key for ADHD? They allow doctors to identify potential underlying health conditions, such as heart problems, that could be exacerbated by ADHD medication.
- What is NICE guidance on ADHD medication? NICE guidelines mandate a full physical assessment, including a cardiovascular history and heart examination, before starting treatment.
- Is ADHD medication safe? Research suggests the benefits generally outweigh the risks, but proper assessment and monitoring are crucial.
Pro Tip: If you are considering private ADHD assessment, always check the provider’s credentials and ensure they offer comprehensive in-person evaluations.
Did you know? The number of patients in England receiving ADHD medication increased by 19% in the year leading up to March 2024.
Have you or a family member navigated the ADHD diagnosis process? Share your experiences in the comments below!
